FHTXVSGTBP• 6 Months (Normalized)
FHTX vs GTBP (Foghorn Therapeutics Inc. vs GT Biopharma Inc.)
Showing Closing Date Range from Apr 8 to Oct 5, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
FHTX Performance $2
-59.1%
Foghorn Therapeutics Inc.
Normalized Baseline0.00%
GTBP Performance $6.16
+1420.99%
GT Biopharma Inc.
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
-1480.09 pts
GTBP outperforming by 1480.09 percentage points
FHTXGTBP
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
FHTX GTBP
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(123 dates)
| Date | FHTX Price | FHTX Gain (%) | GTBP Price | GTBP Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 05, 2026 | $2.00 | -59.10% | $6.16 | +1420.99% | -1480.09% |
| Oct 02, 2026 | $2.02 | -58.69% | $6.10 | +1406.17% | -1464.86% |
| Sep 29, 2026 | $- | $6.88 | +1597.53% | - | |
| Sep 28, 2026 | $- | $6.80 | +1579.01% | - | |
| Sep 25, 2026 | $3.54 | -27.61% | $6.89 | +1601.23% | -1628.84% |
| Sep 24, 2026 | $3.60 | -26.38% | $6.83 | +1586.42% | -1612.80% |
| Sep 23, 2026 | $3.87 | -20.86% | $7.10 | +1653.09% | -1673.95% |
| Sep 22, 2026 | $4.24 | -13.29% | $- | - | |
| Sep 21, 2026 | $4.15 | -15.13% | $7.18 | +1672.84% | -1687.97% |
| Sep 18, 2026 | $4.14 | -15.34% | $7.16 | +1667.90% | -1683.24% |
| Sep 17, 2026 | $4.20 | -14.11% | $7.49 | +1749.38% | -1763.49% |
| Sep 16, 2026 | $4.17 | -14.72% | $7.81 | +1828.40% | -1843.12% |
| Sep 15, 2026 | $4.12 | -15.75% | $9.00 | +2122.22% | -2137.97% |
| Sep 14, 2026 | $4.36 | -10.84% | $11.63 | +2771.60% | -2782.44% |
| Sep 11, 2026 | $4.42 | -9.61% | $8.61 | +2025.93% | -2035.54% |
Page 1 of 9